Compare OSK & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSK | CAI |
|---|---|---|
| Founded | 1917 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.0B |
| IPO Year | N/A | 2025 |
| Metric | OSK | CAI |
|---|---|---|
| Price | $149.61 | $26.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $152.67 | $34.71 |
| AVG Volume (30 Days) | 646.0K | ★ 2.3M |
| Earning Date | 01-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.34% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.25 | N/A |
| Revenue | ★ $10,331,600,000.00 | $649,062,000.00 |
| Revenue This Year | N/A | $77.47 |
| Revenue Next Year | $5.72 | $35.87 |
| P/E Ratio | $14.86 | ★ N/A |
| Revenue Growth | N/A | ★ 112.02 |
| 52 Week Low | $76.82 | $22.86 |
| 52 Week High | $155.71 | $42.50 |
| Indicator | OSK | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 65.14 | N/A |
| Support Level | $125.51 | N/A |
| Resistance Level | $155.71 | N/A |
| Average True Range (ATR) | 4.49 | 0.00 |
| MACD | 1.15 | 0.00 |
| Stochastic Oscillator | 79.57 | 0.00 |
Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (49% of revenue), Vocational (31%), and Transport (20%) on 2024 revenue of $10.7 billion.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.